240 Capsules, Each With 500mg of L-Carnitine Tartrate
Shortage list update: Tirzepatide was removed from the FDA drug shortage list in early 2025
Contact your healthcare provider if you experience: Persistent or severe hunger that doesn't improve after the initial titration period (typically 812 weeks) Unintended weight gain whilst taking Ozempic, particularly if accompanied by increased appetite Symptoms of hypoglycaemia including shakiness, sweating, confusion, or palpitations, especially if occurring frequently Difficulty managing your diabetes with worsening HbA1c levels or consistently elevated blood glucose readings Significant changes in eating patterns or concerns about disordered eating behaviours Seek urgent medical attention if you develop: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Symptoms of gallstones such as pain in the upper right abdomen, particularly after eating Persistent vomiting leading to dehydration Signs of allergic reaction such as rash, swelling, or difficulty breathing Your GP may need to review your treatment plan , which could involve adjusting the Ozempic dose, evaluating the timing of administration, or assessing interactions with other medications
Zepbound is a brand name drug that contains tirzepatide, an injectable medication that acts on incretin pathways involved in appetite regulation and digestion
